Michal Tomasz Marzec

Michal Tomasz Marzec

Guest researcher


  1. 2009
  2. Anaplastic lymphoma kinase (ALK)-induced malignancies: novel mechanisms of cell transformation and potential therapeutic approaches

    Wasik, M. A., Zhang, Q., Marzec, Michal Tomasz, Kasprzycka, M., Wang, H. Y. & Liu, X., 2009, In: Seminars in Oncology. 36, 2 Suppl 1, p. S27-35

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2010
  4. Plasma gelsolin modulates cellular response to sphingosine 1-phosphate

    Bucki, R., Kulakowska, A., Byfield, F. J., Zendzian-Piotrowska, M., Baranowski, M., Marzec, Michal Tomasz, Winer, J. P., Ciccarelli, N. J., Gorski, J., Drozdowski, W., Bittman, R. & Janmey, P. A., 2010, In: American Journal of Physiology: Cell Physiology. 299, 6, p. C1516-23

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2011
  6. Published

    Oncogenic kinase NPM/ALK induces expression of HIF1 alpha mRNA

    Marzec, Michal Tomasz, Liu, X., Wong, W., Yang, Y., Pasha, T., Kantekure, K., Zhang, P., Woetmann, Anders , Cheng, M., Ødum, Niels & Wasik, M. A., 2011, In: Oncogene. 30, 11, p. 1372-1378 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells

    Marzec, Michal Tomasz, Liu, X., Wysocka, M., Rook, A. H., Ødum, Niels & Wasik, M. A., 16 Sep 2011, In: PLoS ONE. 6, 9, 8 p., e24849.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. 2012
  9. Prediction and Early Detection of Response by NMR Spectroscopy and Imaging

    Lee, S., Arias-Mendoza, F., Poptani, H., Delikatny, E. J., Wasik, M., Marzec, Michal Tomasz, Schuster, S. J., Nasta, S. D., Svoboda, J., O'Connor, O. A., Smith, M. R. & Glickson, J. D., Jan 2012, In: PET Clinics. 7, 1, p. 119-26 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum

    Marzec, Michal Tomasz, Eletto, D. & Argon, Y., Mar 2012, In: B B A - Reviews on Cancer. 1823, 3, p. 774-87 14 p.

    Research output: Contribution to journalReviewResearchpeer-review

  11. 2013
  12. Decreased lactate concentration and glycolytic enzyme expression reflect inhibition of mTOR signal transduction pathway in B-cell lymphoma.

    Lee, S., Marzec, Michal Tomasz, Liu, X., Wehrli, S., Kantekure, K., Ragunath, P. N., Nelson, D. S., Delikatny, E. J., Glickson, J. D. & Wasik, M. A., 2013, In: NMR in Biomedicine. 26, 1, p. 106-114 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming

    Marzec, Michal Tomasz, Halasa, K., Liu, X., Wang, H. Y., Cheng, M., Baldwin, D., Tobias, J. W., Schuster, S. J., Woetmann, Anders , Zhang, Q., Turner, S. D., Ødum, Niels & Wasik, M. A., 15 Dec 2013, In: Journal of immunology (Baltimore, Md. : 1950). 191, 12, p. 6200-7 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. 2014
  15. Variation in GRP94 Activity Impacts Production of Igfs and Human Growth

    Argon, Y., Grimberg, A., Rosenfeld, R. G. & Marzec, Michal Tomasz, 2014, In: Endocrine Reviews. 35, 3

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. 2016
  17. Utility of blood procalcitonin concentration in the management of cancer patients with infections

    Durnas, B., Watek, M., Wollny, T., Niemirowicz, K., Marzec, Michal Tomasz, Bucki, R. & Gozdz, S., 2016, In: OncoTargets and Therapy. 9, p. 469-475

    Research output: Contribution to journalReviewResearchpeer-review

ID: 129941679